FG-2216 Uses, Dosage, Side Effects and more
A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.
| Attribute | Details |
|---|---|
| Trade Name | FG-2216 |
| Generic | FG-2216 |
| Type | |
| Formula | C12H9ClN2O4 |
| Weight | Average: 280.664 Monoisotopic: 280.025084493 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in anemia and kidney disease.
